<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3250">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02008201</url>
  </required_header>
  <id_info>
    <org_study_id>D-status</org_study_id>
    <nct_id>NCT02008201</nct_id>
  </id_info>
  <brief_title>Vitamin D Status and Supplementation in Athletes</brief_title>
  <acronym>D-status</acronym>
  <official_title>Vitamin D Status and Supplementation in Elite Athletes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wageningen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wageningen University</source>
  <oversight_info>
    <authority>The Netherlands: Wageningen University</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this study are 1) to assess the prevalence of vitamin D deficiency in a
      group of sub elite athletes and 2) to identify seasonal changes in vitamin D status and the
      effect that supplementation may have during the course of a year.

      The study is a double blinded parallel study design. Study population: 175 elite/ sub elite
      athletes, male and female, aged 18-60y, from a variety of sport disciplines
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in serum 25(OH)D</measure>
    <time_frame>Every 3 months during one year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">175</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Vitamin D dose 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D dose 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D dose 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D dose 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D dose 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vitamin D dose 3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>observational</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D</intervention_name>
    <arm_group_label>Vitamin D dose 1</arm_group_label>
    <arm_group_label>Vitamin D dose 2</arm_group_label>
    <arm_group_label>Vitamin D dose 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  athletes

          -  19-60y

        Exclusion Criteria:

          -  subjects who take vitamin D supplements
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisette de Groot, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wageningen University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wageningen University</name>
      <address>
        <city>Wageningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 5, 2013</lastchanged_date>
  <firstreceived_date>September 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dose-response study</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
